#VisualAbstract: Ruxolitinib use may be associated with higher incidences of nonmelanoma skin cancers
Click to read this study in the Journal of the American Academy of Dermatology.
Read More
studygraphics
#VisualAbstract: Daprodustat noninferior to darbepoetin alfa in the treatment of anemia in patients with chronic kidney disease on incident dialysis
1. This trial demonstrated noninferiority of daprodustat to darbepoetin alfa in the treatment of...
Read More
#VisualAbstract: Bone mineral density testing beneficial for older men receiving androgen deprivation therapy for localized or regional prostate cancer
1. Bone mineral density testing was associated with a significant decreased risk of developing...
Read More
#VisualAbstract: Nivolumab plus chemotherapy improves progression-free survival in gastric or gastroesophageal junction cancer
Click to read this study in The Lancet Oncology.
Read More
#VisualAbstract: Solid organ transplant recipients are at an increased risk of developing non-melanoma skin cancers
Click to read this study in JAMA Dermatology.
Read More
#VisualAbstract: Tumor response-adapted treatment based on radiotherapy may improve rates of laryngeal preservation
Click to read this study in JAMA Network Open.
Read More
#VisualAbstract: Neoadjuvant HD201 shows similar efficacy to referent trastuzumab for ERBB2-positive breast cancer
Click to read this study in JAMA Oncology.
Read More
#VisualAbstract: Cardiosphere-derived cell therapy slows disease progression in Duchenne muscular dystrophy
Cardiosphere-derived cell therapy (CAP-1002) slowed loss of upper limb function by 71% compared to...
Read More
#VisualAbstract: Donidalorsen reduces attacks in patients with hereditary angioedema
Patients with hereditary angioedema receiving donidalorsen showed reduced rates of angioedema attacks compared to patients receiving placebo treatment. Donidalorsen shows an acceptable safety profile after four doses. Evidence...
Read More
#VisualAbstract: Non-severe tuberculosis in children can be treated with a shorter 4-month regimen instead of 6-month regimen
For children with non-severe tuberculosis, 4 months of antituberculosis treatments was...
Read More
#VisualAbstract:
Three Covid-19 vaccines from Pfizer, Moderna, and Johnson & Johnson provided durable...
Read More
#VisualAbstract: Pertuzumab plus trastuzumab significantly improves survival in metastatic breast cancer
Click to read this study in JAMA Network Open.
Read More